Log in to search using one of your social media accounts:

 

Neuren to conduct first phase 3 clinical trial for Rett Syndrome
(Rettsyndrome.org) Rettsyndrome.org is pleased to share that Neuren Pharmaceuticals, today, after meeting with the FDA, will conduct a Phase 3 clinical trial for trofinetide, a compound that shows great promise in the treatment of Rett syndrome, in children and adults. This critical Phase 3 trial will be the final clinical step before FDA approval to become a prescribable drug. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 12, 2017 Category: Biology Source Type: news

What Causes Microcephaly?
Patient Presentation A 5-month-old male came to clinic for his health supervision visit and followup from his neonatal intensive care stay. He was born prematurely at 28 weeks gestation and his stay was complicated by a right sided Grade III intraventricular hemorrhage, a left-sided Grade IV intraventricular hemorrhage, neonatal seizures, respiratory distress and bronchopulmonary dysplasia, retinopathy of prematurity, acute kidney injury that had resolved, possible necrotizing enterocolitis incidents x 2, and herpes simplex encephalitis. He was on home oxygen, a nasogastric feeding tube because of aspiration risk and mult...
Source: PediatricEducation.org - September 25, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Discovery fuels hope for Rett syndrome treatment
(Vanderbilt University Medical Center) Vanderbilt University researchers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 23, 2017 Category: International Medicine & Public Health Source Type: news

Drug improves brain performance in Rett syndrome mice
(University of Alabama at Birmingham) A brain penetrant drug -- a small-molecule mimetic of BDNF, or brain derived neurotrophic factor -- is able to improve brain performance in Rett syndrome mice -- specifically synaptic plasticity in the hippocampus and object location memory. The hippocampus is involved in learning and memory. The drug also increased the distance mice traveled in an open field test, a measure of general locomotor activity, to normal levels. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2017 Category: International Medicine & Public Health Source Type: news

Seven lessons I ’ve learned from Rett syndrome
As a mother of a child with Rett syndrome, a disability that affects the brain’s ability to plan or coordinate motor skills, the phrase “take for granted” takes on a whole new meaning. I cannot take for granted that Ava can recite her A, B, C’s or feed herself a snack or go to the bathroom on her own. Quite the opposite. Every day, I strive to properly appreciate the effort it takes for Ava to perform the most mundane tasks. I am the one being “schooled” on Rett syndrome. Here are seven of the things Rett syndrome has taught me: 1. Technology is seriously cool.  Ava doesn’t sp...
Source: Thrive, Children's Hospital Boston - July 18, 2017 Category: Pediatrics Authors: Joanne Gryniewicz Tags: Our Patients’ Stories rett syndrome Source Type: news

Biohaven's BHV-5000 Receives Orphan Drug Designation from the FDA in Rett Syndrome
NEW HAVEN, Conn., July 6, 2017 -- (Healthcare Sales & Marketing Network) -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced today that BHV-5000, an investigational compound in the company's glutamate modulation platform, has been grant... Biopharmaceuticals, Neurology, FDA Biohaven Pharmaceutical, BHV-5000, Rett syndrome, orphan drug designation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2017 Category: Pharmaceuticals Source Type: news

Personalized metabolic therapy treatment shows improvement on atypical Rett syndrome
(IDIBELL-Bellvitge Biomedical Research Institute) Administration of the amino acid D-serine, a dietary supplement, contributes to the improvement of the cognitive and motor capacity of a patient with a mutation that affects glutamate receptors (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 4, 2017 Category: International Medicine & Public Health Source Type: news

David Geffen School of Medicine at UCLA names winner of Switzer Prize for research excellence
Dr. Huda Zoghbi, a neurologist whose work has revealed the molecular basis of neurological disorders, is the recipient of the 2017 Switzer Prize awarded by theDavid Geffen School of Medicine at UCLA for excellence in biological and biomedical sciences research.Zoghbi ’s lab at the Baylor College of Medicine identified a gene mutation that causes Rett syndrome, a severe genetic disorder that mostly affects girls. After a short period of apparently normal development, the disorder causes them to lose language and motor skills, typically by 18 months of age. The discovery paved the way for a genetic test to diagnose the...
Source: UCLA Newsroom: Health Sciences - June 19, 2017 Category: Universities & Medical Training Source Type: news

A Vote To Gut Medicaid Is A Vote Against Families
In response to imminent threats to Medicaid, The Arc produced a series of videos which share personal stories of people with disabilities and their families, and highlight the vital importance of Medicaid in gaining access to the home and community based supports and services needed to live independent and fulfilling lives. Meet Soojung. Her 11 year-old daughter, Alice, has Rett Syndrome and relies on overnight nursing services to be able to live at home with her family. Watch as Linda from North Carolina tells the story of how Medicaid changed her son Javi’s life. Listen to Bryan tell his story abou...
Source: Healthy Living - The Huffington Post - June 14, 2017 Category: Consumer Health News Source Type: news

AveXis to Advance Gene Therapy Program Initiated by the Rett Syndrome...
The Rett Syndrome Research Trust (RSRT) is excited to announce that AveXis, Inc., has committed to advance a gene therapy candidate for Rett Syndrome into human clinical trials.(PRWeb June 08, 2017)Read the full story at http://www.prweb.com/releases/2017/06/prweb14408379.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 8, 2017 Category: Pharmaceuticals Source Type: news

Living with Rett syndrome, living with hope
For the first year of her life, Ava Gryniewicz seemed to be developing like any other happy baby. She had learned a few words, including “mama” and “dada,” and was picking up Cheerios with pincer fingers. But by the time she was 14 months old, everything had changed. Ava started to lose these skills and wasn’t reaching other milestones. At the recommendation of her daycare center, she started early intervention. “She wasn’t keeping up and her daycare providers were concerned that standard daycare might be too much for her,” says her mom, Joanne. That’s when Joanne and h...
Source: Thrive, Children's Hospital Boston - June 1, 2017 Category: Pediatrics Authors: Ellen Greenlaw Tags: Our Patients’ Stories Alycia Berg Augmentative communication Dr. Jonathan Picker rett syndrome Rett Syndrome Program Suzanne Rose Source Type: news

Rettsyndrome.org funds additional $775K of new research projects in Q1 2017
(Rettsyndrome.org) The International Rett Syndrome Foundation, now doing business as Rettsyndrome.org, announces the addition of six research projects to its Research Portfolio in the first quarter of 2017. A commitment of $775,000, through research grants, brings the largest non-governmental private funder of Rett research above the recently attained milestone of $40M research dollars to $41M. These funds have continually been designated to accelerate research for Rett syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2017 Category: Global & Universal Source Type: news

Sustained attention in the face of distractors: a study of children with Rett syndrome - Rose SA, Wass S, Jankowski JJ, Feldman JF, Djukic A.
OBJECTIVE: The object of the present study is to advance our understanding of the cognitive profile of Rett syndrome (RTT), an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene. We focus on sustained attention, which plays a critic... (Source: SafetyLit)
Source: SafetyLit - April 11, 2017 Category: Global & Universal Tags: Age: Infants and Children Source Type: news

Neuren reports positive top-line results from Phase II trial of trofinetide for Rett syndrome
Australian-based biopharmaceutical firm Neuren Pharmaceuticals has reported positive top-line results from the Phase II clinical trial of trofinetide to treat girls with Rett syndrome. (Source: Drug Development Technology)
Source: Drug Development Technology - March 26, 2017 Category: Pharmaceuticals Source Type: news

The Rett Syndrome Research Trust Announces Roadmap to Cure Devastating...
Human clinical trials of gene therapy on the horizon.(PRWeb March 22, 2017)Read the full story at http://www.prweb.com/releases/2017/03/prweb14176403.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 23, 2017 Category: Pharmaceuticals Source Type: news

Scientists Uncover Possible Therapeutic Targets for Rare Autism Spectrum Disorder
Researchers have uncovered 30 genes that could, one day, serve as therapeutic targets to reverse Rett syndrome, a rare neurological disorder that affects only girls and is a severe form of an autism spectrum disorder. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 31, 2017 Category: Science Source Type: news

In Rett syndrome model, team shows how adult learning is impaired in females
In mouse models of Rett syndrome -- which in humans is seen overwhelmingly in females -- researchers have demonstrated how failure of Mecp2, the mouse equivalent of the human gene of the same name, has biological consequences that prevent adult females from learning how to gather newborn pups in the days immediately following the pups'birth. They reversed the defect. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 18, 2017 Category: Science Source Type: news

In Rett syndrome model, team shows how adult learning is impaired in females
(Cold Spring Harbor Laboratory) In mouse models of Rett syndrome -- which in humans is seen overwhelmingly in females -- researchers have demonstrated how failure of Mecp2, the mouse equivalent of the human gene of the same name, has biological consequences that prevent adult females from learning how to gather newborn pups in the days immediately following the pups' birth. They reversed the defect. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 18, 2017 Category: Global & Universal Source Type: news

Rettsyndrome.org reaches milestone of $40 million in research funding
(Rettsyndrome.org) The International Rett Syndrome Foundation, now doing business as Rettsyndrome.org, announces today that Rettsyndrome.org has reached a milestone in research funding. The leading foundation for Rett research has distributed over $40 million dollars to accelerate treatments for Rett syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2017 Category: Global & Universal Source Type: news

Neuren Pharmaceuticals completes enrolment for Phase II trial of trofinetide to treat Rett syndrome
US-based biopharmaceutical company Neuren has completed enrolment for its Phase II clinical trial of trofinetide in pediatric Rett syndrome. (Source: Drug Development Technology)
Source: Drug Development Technology - November 15, 2016 Category: Pharmaceuticals Source Type: news

Ed Sheeran serenades a nine-year-old superfan at her hospital bed  
Rocker Ed Sheeran has made a young superfan's dream come true by visiting her in hospital in Surrey to serenade her. Melody Driscoll, nine, suffers from the rare brain condition, Rett syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2016 Category: Consumer Health News Source Type: news

Newron begins STARS study of sarizotan to treat Rett syndrome
Italian-based biopharmaceutical company Newron Pharmaceuticals has begun the Sarizotan Treatment of Apneas in Rett Syndrome (STARS) study of sarizotan to treat Rett syndrome. (Source: Drug Development Technology)
Source: Drug Development Technology - July 24, 2016 Category: Pharmaceuticals Source Type: news

Insights into neurons that cause symptoms of Rett syndrome could guide new therapy search
Two studies in mice reveal new insights into neurons that mediate symptoms typical of the postnatal neurological disorder Rett syndrome. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 28, 2016 Category: Science Source Type: news

Insights into neurons that cause symptoms of Rett syndrome could guide new therapy search
(eLife ) Two studies in mice from Baylor College of Medicine, Texas, reveal new insights into neurons that mediate symptoms typical of the postnatal neurological disorder Rett syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2016 Category: Global & Universal Source Type: news

i-Fect used to Study Epigenetics in Nerve Injury
Conclusions: The study shows a regulatory role for MeCP2 in that changes in global redistribution can result in direct and indirect modulation of gene expression in the DRG. Alterations in genome-wide binding of MeCP2 therefore provide a molecular basis for a better understanding of epigenetic regulation-induced molecular changes underlying nerve injury. (Source: siRNA and DsiRNA Transfection Efficiency)
Source: siRNA and DsiRNA Transfection Efficiency - June 20, 2016 Category: Neuroscience Tags: i-Fect MeCP2 Methyl-CpG-binding protein 2 miR-126 miRNA Delivery Methods Nerve Injury. Source Type: news

MeCP2 and Nerve Injury
Conclusions: The study shows a regulatory role for MeCP2 in that changes in global redistribution can result in direct and indirect modulation of gene expression in the DRG. Alterations in genome-wide binding of MeCP2 therefore provide a molecular basis for a better understanding of epigenetic regulation-induced molecular changes underlying nerve injury. (Source: Neuromics)
Source: Neuromics - June 20, 2016 Category: Neuroscience Tags: Delivering siRNA to the CNS epigenetics gene expression analysis i-Fect MECP2 methyl-CpG-binding protein 2 miR-126 Nerve Injury Nerve Sprouting Source Type: news

Dad Fights For Cure For His Daughter's Disorder In Emotional Video
In August 2014, dad A.J. Tesler created a short video with the title "Save My Daughter. Share This Video." Eight months earlier, his toddler daughter Magnolia (aka "Maggie") had been diagnosed with a rare neurological disorder called Rett syndrome, and all YouTube ad revenue generated from the video would go toward funding clinical trial research to find a cure. Now the dad is continuing his fight to find a cure -- for his daughter and the 350,000 other girls and women affected by Rett syndrome. The debilitating disorder almost exclusively affects girls and generally involves slowed developmen...
Source: Science - The Huffington Post - May 18, 2016 Category: Science Source Type: news

Dad Fights For Cure For His Daughter's Disorder In Emotional Video
In August 2014, dad A.J. Tesler created a short video with the title "Save My Daughter. Share This Video." Eight months earlier, his toddler daughter Magnolia (aka "Maggie") had been diagnosed with a rare neurological disorder called Rett syndrome, and all YouTube ad revenue generated from the video would go toward funding clinical trial research to find a cure. Now the dad is continuing his fight to find a cure -- for his daughter and the 350,000 other girls and women affected by Rett syndrome. The debilitating disorder almost exclusively affects girls and generally involves slowed developmen...
Source: Healthy Living - The Huffington Post - May 18, 2016 Category: Consumer Health News Source Type: news

Rett Syndrome Research Trust Awards $9 Million to Accelerate...
Today the Rett Syndrome Research Trust (RSRT) announced research awards totaling nearly $9 million in 2015. This is the most research ever awarded in a given year by any Rett Syndrome organization.(PRWeb March 10, 2016)Read the full story at http://www.prweb.com/releases/2016/03/prweb13254722.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 11, 2016 Category: Pharmaceuticals Source Type: news

The Rett Syndrome Research Trust Names Randall L. Carpenter as Chief...
The Rett Syndrome Research Trust (RSRT) is delighted to announce that Randall L. Carpenter is joining the organization in the role of Chief Scientific Officer. In this newly created position, Dr....(PRWeb February 25, 2016)Read the full story at http://www.prweb.com/releases/2016/02/prweb13230397.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 25, 2016 Category: Pharmaceuticals Source Type: news

Nemmers Prize in Medical Science awarded by Northwestern
(Northwestern University) Dr. Huda Zoghbi, a Howard Hughes Medical Institute investigator and professor at Baylor College of Medicine known for her groundbreaking research on Rett syndrome and other neurological disorders, is the inaugural recipient of the Mechthild Esser Nemmers Prize in Medical Science at Northwestern University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 3, 2016 Category: Global & Universal Source Type: news

New drug target for Rett syndrome
A faulty signaling pathway has been identified that, when corrected, in mice ameliorates the symptoms of Rett syndrome, a devastating neurological condition. The findings could lead to the discovery of compounds or drugs that may benefit children affected by the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 2, 2016 Category: Science Source Type: news

New drug target for Rett syndrome
Harvard Stem Cell Institute (HSCI) researchers have identified a faulty signaling pathway that, when corrected, in mice ameliorates the symptoms of Rett syndrome, a devastating neurological condition. The findings could lead to the discovery of compounds or drugs that may benefit children affected by the disease, (Source: World Pharma News)
Source: World Pharma News - February 2, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

New drug target for Rett syndrome
(Harvard Medical School) Harvard Stem Cell Institute researchers have identified a faulty signaling pathway that, when corrected, in mice ameliorates the symptoms of Rett syndrome, a devastating neurological condition. The findings could lead to the discovery of compounds or drugs that may benefit children affected by the disease, says neurobiologist Jeffrey Macklis, Max and Anne Wien Professor of Life Sciences in the Department of Stem Cell and Regenerative Biology, and Center for Brain Science, at Harvard University, who directed the work. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 2, 2016 Category: Global & Universal Source Type: news

'Autistic' monkeys created in controversial study
ConclusionThis animal study genetically modified monkeys to carry the MECP2 gene to assess whether they would exhibit autism-like behaviours and pass this gene on to offspring.  The researchers found that the modified monkeys did show some autism-like behaviours, namely an increase in repetitive circular motion, increased anxiety and reduced social interaction. It has been welcomed by some experts in the field, who feel this is potentially very important and could allow greater understanding of autism. However, as mentioned, other experts have argued that while the research is impressive in terms of technical expertis...
Source: NHS News Feed - January 26, 2016 Category: Consumer Health News Tags: Neurology Mental health Medical practice Source Type: news

Toddler with Rett syndrome sees her development 'going backwards'
Queensland's Marc and Dana Beckett's daughter, two-year-old Maika, has Rett syndrome. The rare condition means she will not be able to walk or talk, and her development has gone backwards. (Source: the Mail online | Health)
Source: the Mail online | Health - January 20, 2016 Category: Consumer Health News Source Type: news

What Types of Hand Stereotypies are Associated with Rett Syndrome?
Discussion Lady MacBeth and patients with Rett Syndrome (RS) are obviously not alike other than in making similar hand motions. In Shakespeare’s MacBeth (5.1.25-30), Lady MacBeth was driven into madness because of her murderous guilt and tries to wash the blood off her hands as she sleepwalks. Doctor. What is it she does now? Look, how she rubs/ her hands. Gentlewoman. It is an accustomed action with her, to seem thus/ washing her hands. I have known her continue in this/ a quarter of an hour. In 1954, Dr. Andreas Rett observed 2 girls who were also making repetitive handwashing motions and later published a case...
Source: PediatricEducation.org - January 11, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Rettsyndrome.org invests $65,000 to support additional sites for natural history study
(International Rett Syndrome Foundation) Last year, the NIH National Center for Advancing Translational Science Rare Diseases Clinical Research Network funded the development of a consortium made up of 11 sites to study the natural history of Rett syndrome, MECP2 Duplication, CDKL5 disorder, and FOXG1 syndrome under their strong belief that collaborative activities are necessary to advance rare disease research. As a private rare disease foundation, Rettsyndrome.org knows that the benefits of partnering with other organizations dedicated to MECP2 and related disorders research are immeasurable. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 22, 2015 Category: Global & Universal Source Type: news

MECP2 duplication syndrome is reversible
(Rett Syndrome Research Trust) Research led by Huda Zoghbi, M.D., at Baylor College of Medicine and HHMI and published today in the journal Nature reveals that the MECP2 Duplication Syndrome is reversible. Importantly the study paves the way for treating duplication patients with an antisense oligonucleotide strategy. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 25, 2015 Category: Global & Universal Source Type: news

Rett Syndrome Association of Massachusetts and Rettsyndrome.org continue their partnership
(International Rett Syndrome Foundation) The Rett Syndrome Association of Massachusetts and Rettsyndrome.org announce today their renewed commitment to work together to defeat Rett syndrome. A generous $85,000 donation from RSAM will support an ongoing clinical trial for Rettsyndrome.org at Boston Children's Hospital. The trial is funded by a Rettsyndrome.org ANGEL grant to Dr. Walter Kaufmann for a Phase 2b clinical study of IGF-1. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 12, 2015 Category: Global & Universal Source Type: news

Running To Overcome A Disease: One Family's Battle With Rett Syndrome
Until she was 18 months old, Maria Ferre was a healthy baby. Suddenly, she was struck with Rett syndrome, a physically debilitating condition that affects approximately 1 in 15,000 female children worldwide. Symptoms of Rett syndrome include loss of speech and motor control. In Maria’s case, it resulted in extreme disability. Faced with the powerlessness that accompanies fighting a condition without a cure and without widespread public attention, her father, Josele, turned to his passion to help raise awareness. He started running marathons with his daughter, pushing her in a stroller, while the wind caressed her fac...
Source: Healthy Living - The Huffington Post - August 7, 2015 Category: Consumer Health News Source Type: news

A cause of mental retardation, autism discovered
The term intellectual disability covers a large number of clinical entities, some with known cause and others of uncertain origin. For example Down syndrome is due to an extra copy of chromosome 21 and Rett syndrome is in part caused by a mutation in the control switch gene called MeCP2. In other cases the mechanisms by which they are produced are not clearly identified. Now a research team has discovered a mechanism that identifies a cause of intellectual disabilities in these puzzling cases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 20, 2015 Category: Science Source Type: news

Discovered a cause of mental retardation and autism
(IDIBELL-Bellvitge Biomedical Research Institute) The term intellectual disability covers a large number of clinical entities, some with known cause and others of uncertain origin. For example Down syndrome is due to an extra copy of chromosome 21 and Rett syndrome is in part caused by a mutation in the control switch gene called MeCP2. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 20, 2015 Category: Biology Source Type: news

Rettsyndrome.org announces new 2015 Translational Research Awards
(International Rett Syndrome Foundation) Rettsyndrome.org announces today that the Board of Trustees has awarded $1M to launch the Read-Through Program, further translational research in the area of neuro-habilitation, and fund clinical research. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 25, 2015 Category: Global & Universal Source Type: news

Lily cannot walk or talk due to cruel genetic disease Rett syndromen
Lily Hall, from Surrey, has Rett syndrome - a rare, life-limiting, genetic condition which has stopped her development in its tracks - meaning she will never be able to walk or talk. (Source: the Mail online | Health)
Source: the Mail online | Health - June 23, 2015 Category: Consumer Health News Source Type: news

New Drug for Rett Syndrome?New Drug for Rett Syndrome?
Research shows that a new investigational drug is safe, well tolerated, and effective in managing core symptoms of this neurodegenerative genetic disorder. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 22, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

#Dance4Rett and Rettsyndrome.org Raising Awareness and Funding for...
Viral campaign started by parents of girls with Rett syndrome builds community and momentum toward treatments.(PRWeb May 15, 2015)Read the full story at http://www.prweb.com/releases/2015/05/prweb12726116.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2015 Category: Pharmaceuticals Source Type: news

New research implicates immune system in Rett syndrome
The immune system plays an unsuspected and surprising role in the progression of Rett syndrome, a severe neurological disorder affecting children, new research suggests. Rett syndrome is a neurodevelopmental disorder that is caused primarily by mutations in the gene encoding for MeCP2, an important epigenetic regulator. Children with the disorder appear to develop normally but begin to lose acquired cognitive and motor skills at 6 to 18 months of age as symptoms start to show. As they age, patients are unable to acquire verbal skills and suffer from lack of motor control. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 11, 2015 Category: Science Source Type: news

New research implicates immune system in Rett syndrome
(University of Massachusetts Medical School) New research by investigators at the University of Massachusetts Medical School suggests the immune system plays an unsuspected and surprising role in the progression of Rett syndrome, a severe neurological disorder affecting children. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 11, 2015 Category: Biology Source Type: news

A biomarker for Rett syndrome: Measuring hand movements
We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital. By Alice McCarthy Boston Children's HospitalNews Well, Vector Blog, Big Data, Blogread more (Source: Mass Device)
Source: Mass Device - April 29, 2015 Category: Medical Equipment Authors: MassDevice Tags: Vector Blog Source Type: news